GenSight Biologics S.A. has appointed Mohamed Genead as Chief Medical Officer of the company. The appointment is effective from May 1, 2017. Prior to this appointment, Genead worked for Biogen as Vice President & Global Therapeutic Area Head for Ophthalmology/Retina Gene Therapy. He has also worked with GLG (Gerson Lehrman Group), Allegro Ophthalmics and Allergan.